Ripple Labs is seeking April 16, 2025, as its deadline to submit their cross-appeal brief pertaining to its ongoing legal contention with the US Securities and Exchange Commission. This request followed the January 15, 2025, filing by the SEC where they contended that the judicial decision taken by the New York District Court, ruling that XRP offered for sale to the retail investors did not fall under the ambit of securities, was incorrect.
The SEC also stated that XRP was given to compensate employees, and in business details, it was erroneously ruled out as security.
Image by Miloslav Hamřík from Pixabay